A detailed history of Northwestern Mutual Wealth Management CO transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 28 shares of PDSB stock, worth $94. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Holding current value
$94
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$2.55 - $4.02 $71 - $112
28 New
28 $0
Q1 2022

May 09, 2022

SELL
$4.78 - $8.43 $205 - $362
-43 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$7.76 - $14.35 $333 - $617
43 New
43 $0

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $95.9M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.